These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31744643)

  • 1. Noninvasive Detection and Localization of Genitourinary Cancers Using Urinary Sediment DNA Methylomes and Copy Number Profiles.
    Xu Z; Ge G; Guan B; Lei Z; Hao X; Zhou Y; Shi Y; Lu H; Wang J; Peng D; Wu X; He H; Zhang B; Li X; Zhou L; Ci W
    Eur Urol; 2020 Feb; 77(2):288-290. PubMed ID: 31744643
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Zhengzheng Xu, Guangzhe Ge, Bao Guan, et al. Noninvasive Detection and Localization of Genitourinary Cancers Using Urinary Sediment DNA Methylomes and Copy Number Profiles. Eur Urol 2020;77:288-90.
    Wang Y; Xiong Y; Wang X
    Eur Urol; 2020 Apr; 77(4):e90. PubMed ID: 31892481
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Yejinpeng Wang, Yaoyi Xiong, and Xinghuan Wang's Letter to the Editor re: Zhengzheng Xu, Guangzhe Ge, Bao Guan, et al. Noninvasive Detection and Localization of Genitourinary Cancers Using Urinary Sediment DNA Methylomes and Copy Number Profiles. Eur Urol 2020;77:288-90.
    Zhengzheng X; Ge G; Guan B; Lei Z; Hao X; Zhou Y; Shi Y; Lu H; Wang J; Peng D; Wu X; He H; Zhang B; Li X; Zhou L; Ci W
    Eur Urol; 2020 Apr; 77(4):e91-e92. PubMed ID: 31892480
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhanced Detection of Genitourinary Cancers Using Fragmentation and Copy Number Profiles Obtained from Urinary Cell-Free DNA.
    Han Y; Li X; Zhang M; Yang Y; Ge G; Wang K; Gong Y; Liang Y; Niu H; Ci W
    Clin Chem; 2021 Jan; 67(2):394-403. PubMed ID: 33523215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genitourinary Cancers Other than Prostate Cancer in a BRCA-tested Cohort from a Single Institution.
    Alanee S; Schrader K; Offit K
    Eur Urol; 2015 Jun; 67(6):1196-1197. PubMed ID: 25597019
    [No Abstract]   [Full Text] [Related]  

  • 6. Accuracy of cytologic examination of urinary sediment in the detection of urothelial tumors.
    Brannan W; Lucas TA; Mitchell WT
    J Urol; 1973 Mar; 109(3):483-5. PubMed ID: 4734982
    [No Abstract]   [Full Text] [Related]  

  • 7. Methods of early diagnosis in genitourinary cancer.
    Guinan P; Rubenstein M
    Cancer; 1987 Aug; 60(3 Suppl):668-76. PubMed ID: 3297292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evaluation of urinary polyamines in the diagnosis of genitourinary tract malignancy.
    Sanford EJ; Drago JR; Rohner TJ; Kessler GF; Sheehan L; Lipton A
    J Urol; 1975 Feb; 113(2):218-21. PubMed ID: 1113419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial factors in cancer of the genitourinary tract.
    Ponz de Leon M
    Recent Results Cancer Res; 1994; 136():306-21. PubMed ID: 7863102
    [No Abstract]   [Full Text] [Related]  

  • 10. Pediatric genitourinary tumors.
    Buckley KS
    Curr Opin Oncol; 2011 May; 23(3):297-302. PubMed ID: 21460723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.
    Sokolova IA; Halling KC; Jenkins RB; Burkhardt HM; Meyer RG; Seelig SA; King W
    J Mol Diagn; 2000 Aug; 2(3):116-23. PubMed ID: 11229514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Sequencing Should Not be Part of the Standard of Care for Most Urologic Cancers.
    Abern MR; Dudinec JV; Inman BA
    Eur Urol Focus; 2022 May; 8(3):639-640. PubMed ID: 35537938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoplasms of the urinary tract.
    Schoonees R
    S Afr Med J; 1972 Nov; 46(44):1654. PubMed ID: 4675645
    [No Abstract]   [Full Text] [Related]  

  • 14. Tetracycline fluorescence in neoplastic urinary sediments.
    Kunin SH; Cooper JF
    Invest Urol; 1967 Mar; 4(5):490-503. PubMed ID: 4960112
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric genitourinary tumors.
    Herz D; McLellan D; Garrels K; Merguerian PA
    Curr Opin Oncol; 2000 May; 12(3):273-81. PubMed ID: 10841201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review.
    Chovanec M; Taza F; Kalra M; Hahn N; Nephew KP; Spinella MJ; Albany C
    Target Oncol; 2018 Feb; 13(1):49-60. PubMed ID: 29230671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early detection of urogenital cancers: kidney, bladder, prostatic and testicular cancers].
    Kawai T; Yamauchi T; Tachibana Y; Yoshino S; Kokuho M
    Gan No Rinsho; 1988 Aug; 34(10):1403-7. PubMed ID: 3172497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urine cytology studies in tumors of the urogenital system].
    Haas P; Kastner H; Wandschneider G
    Wien Med Wochenschr; 1972 Apr; 122(16):225-8. PubMed ID: 5026997
    [No Abstract]   [Full Text] [Related]  

  • 19. Evolving Role of Genomics in Genitourinary Neoplasms.
    Devitt ME; Dreicer R
    Acta Med Acad; 2019 Apr; 48(1):68-77. PubMed ID: 31264434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary polyamine analysis and its clinical significance. II. Analysis by the enzymatic assay method and its clinical application. D. Polyamines in urogenital neoplasms].
    Yagishita T; Kawahara M; Sawamura Y; Matsushima M; Ando K
    Rinsho Byori; 1984 Jul; Spec No 59():82-8. PubMed ID: 6502973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.